Partnering trends and deal analysis reviewed with over 4,000 deals entered by the world’s leading fifty big pharma and big biotech companies.
This deal analysis article is an abstract from the reports: Partnering Deals and Alliances with Big Pharma and Partnering Deals and Alliances with Big Biotech
'Big pharma' or bigpharma is the collective name given to the top pharmaceutical companies in the world ranked by global sales of prescription drugs while big biotech or bigbiotech is the collective name given to the top biotechnology companies in the world ranked by global sales of prescription drugs.
View:
Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering deal talk
Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering deal talk.
Since 2007, there has been a consistent partnering activity by big pharma and big biotech companies as shown in the figures below:
Figure 1: Big pharma partnering 2007-2013
Source: Current Agreements, 2013
Figure 2: Big biotech partnering 2007-2013
Source: Current Agreements, 2013
Below is a list of the top big pharma and biotech players in dealmaking shown in two charts as recorded by Current Agreements database,
Figure 3: Most active big pharma partnering companies 2007-2013
Source: Current Agreements, 2013
Figure 4: Most active big biotech partnering companies 2007-2013
Source: Current Agreements, 2013
Another measure of partnering deal analysis activity apart from the number of deals signed/announced is the size of the deal. Deal size provides an indication of the significance of the deal and the potential opportunity for each party.
Figure 5: Leading big pharma partnering deals by value, 2007-2013
Source: Current Agreements, 2013
Figure 6: Leading big biotech partnering deals by value, 2007-2013
Source: Current Agreements, 2013
The therapeutic areas of focus for both big pharma and big biotech companies have been oncology followed by infectives, CNS and cardiovascular diseases.
The most active M&A dealmakers among the big pharma and biotech are
Figure 7: Most active Big Pharma M&A dealmakers 2007-2013
Source: Current Agreements, 2013
Figure 8: Most active Big Biotech M&A dealmakers 2007-2013
Source: Current Agreements, 2013
The article is an abstract from the report: Partnering Deals and Alliances with Big Pharma and Partnering Deals and Alliances with Big Biotech
The Partnering Deals and Alliances with Big Pharma and Big Biotech reports provide the most comprehensive and in-depth insight into the dealmaking interests and activities of the world’s leading fifty big pharma and biotech companies. It provides the reader with the tools necessary to make successful contact with the right big pharma/ biotech partners effectively and efficiently. The report includes detailed top 50 big pharma/ biotech company profiles, in-depth marketed and pipeline product activity of each company, partnering interests by deal type, phase of development, therapy and technology focus and most active of all big pharma and big biotech companies.. More details here
Sources
The above information has been abstracted from the following resources:
- Partnering Deals and Alliances with Big Pharma
- Partnering Deals and Alliances with Big Biotech
- Current Agreements life sciences partnering, M&A and financing deals database
Related
Buy report: Partnering Deals and Alliances with Big Pharma and Big Biotech
Individual reports: Partnering Deals and Alliances with Big Pharma
Biotech Partnering Terms and Agreements
View: glossary definition for big pharma and big biotech
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter
